Company profile: Deep Origin
1.1 - Company Overview
Company description
- Provider of a cloud-based life sciences R&D platform with customizable bioinformatics and biosimulation workstations, pre-installed tools, and NVIDIA GPUs; a molecular simulation and AI toolkit for compound screening, protein motion prediction, and ADMET; scalable, shareable ComputeBenches (up to 192 vCPUs); expert-curated software blueprints; and team collaboration via Organizations.
Products and services
- Computational R&D Platform: A cloud-based platform delivering customizable bioinformatics and biosimulation workstations with pre-installed software tools and configurable hardware, including NVIDIA GPUs
- ComputeBenches: Scalable and shareable computing configurations with up to 192 vCPUs and NVIDIA GPUs, engineered for ad-hoc analysis and AI model training
- Molecular Simulation Toolkit: A toolkit for physicochemical simulations and AI to screen compounds, predict protein motions, and assess ADMET properties, accessible via Jupyter notebooks on the cloud platform
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Deep Origin
Metis Therapeutics
HQ: United States
Website
- Description: Provider of AI-driven integrated drug discovery and development, combining machine learning, quantum simulation, and high-throughput experimentation; high-throughput in vivo screening to discover LNPs targeting multiple organs; drug delivery and formulation platforms for small molecule and RNA drugs; CMC study design, manufacturing, regulatory filings; and project management for drug discovery and development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Metis Therapeutics company profile →
ScienceIO
HQ: United States
Website
- Description: Provider of a biomedical language platform and AI solutions that transform complex medical text into usable data and insights, detecting biomedical terms, clinical variables, and codes, linking concepts for powerful queries. Offers API access, patient cohorting, digital health message analysis, commercial landscaping, payor workflow digitization, and diagnostics & biomarkers for genomic-driven patient segmentation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ScienceIO company profile →
Deep Lens
HQ: United States
Website
- Description: Provider of a digital pathology workflow platform enabling pathology groups to collaborate on cancer research and accelerate recruitment of cancer patients for clinical trials at diagnosis. Features include AI-powered image detection, workflow support, collaboration, cloud storage, and built-in APIs for ingesting third-party AI models and EMR integration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Deep Lens company profile →
Veracity Logic
HQ: United States
Website
- Description: Provider of interactive response technology solutions for pharma and biotech, featuring a configurable IRT/RTSM platform for patient randomization and trial supply management. Capabilities include mid-study amendments, eligibility and stratification, re-randomization, site shipments, inventory control, kit tracking and expiration, blinded/unblinded batch handling, depot-to-site supply management, and integration with Veeva Development Cloud and third-party apps.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veracity Logic company profile →
Frontier Medicines
HQ: United States
Website
- Description: Provider of a biopharmaceutical drug discovery platform integrating chemoproteomics, covalent chemistry, and machine learning to accelerate medicine development; programs include a dual KRASG12C inhibitor (FMC-376) targeting active and inactive forms in cancers and AutoTAC for autophagy-driven targeted degradation; tools span ML/AI prioritization, chemoproteomics to identify druggable hotspots, and a covalent fragment library.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Frontier Medicines company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Deep Origin
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Deep Origin
2.2 - Growth funds investing in similar companies to Deep Origin
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Deep Origin
4.2 - Public trading comparable groups for Deep Origin
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →